|
CNOT6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.656000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.869700E-02 |
| Normal-vs-Stage2 |
3.989800E-02 |
| Normal-vs-Stage3 |
5.222100E-03 |
| Normal-vs-Stage4 |
7.182600E-04 |
| Stage1-vs-Stage2 |
5.359800E-01 |
| Stage1-vs-Stage3 |
1.231010E-01 |
| Stage1-vs-Stage4 |
3.283800E-02 |
| Stage2-vs-Stage3 |
6.273800E-01 |
| Stage2-vs-Stage4 |
3.229600E-01 |
| Stage3-vs-Stage4 |
5.419400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.596500E-03 |
| Normal-vs-AfricanAmerican |
1.684150E-01 |
| Normal-vs-Asian |
1.589820E-01 |
| Caucasian-vs-AfricanAmerican |
8.258200E-01 |
| Caucasian-vs-Asian |
5.030600E-01 |
| AfricanAmerican-vs-Asian |
7.898600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.676000E-02 |
| Normal-vs-Female |
6.297700E-03 |
| Male-vs-Female |
8.510000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.065440E-01 |
| Normal-vs-Age(41-60Yrs) |
3.437800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.079200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.963600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.615980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.852810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.374200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.236000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.476000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.759700E-02 |
| Classical-VS-Follicular |
1.420710E-03 |
| Classical-VS-Other |
4.058400E-01 |
| Classical-VS-Normal |
1.883350E-01 |
| Tall-VS-Follicular |
9.374400E-01 |
| Tall-VS-Other |
7.588600E-01 |
| Tall-VS-Normal |
2.677300E-03 |
| Follicular-VS-Other |
8.184800E-01 |
| Follicular-VS-Normal |
1.058200E-03 |
| Other-VS-Normal |
1.505610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.317300E-03 |
| Normal-vs-N1 |
5.996900E-03 |
| N0-vs-N1 |
6.564600E-01 |
|
|
